Implanted neurosphere-derived precursors promote recovery after neonatal excitotoxic brain injury

Stem Cells and Development

Volumn 20, Issue 5, 2011, Pages 865-879

  Titomanlio, Luigi ^a,b   Bouslama, Myriam ^a,b   Le Verche, Virginia ^a,b   Dalous, Jérémie ^a,b   Kaindl, Angela M ^a,b,c   Tsenkina, Yanina ^d   Lacaud, Adrien ^d   Peineau, Stéphane ^a,b,e   Ghouzzi, Vincent El ^a,b   Lelièvre, Vincent ^a,b,d   Gressens, Pierre ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMIN; BONE MORPHOGENETIC PROTEIN 5; BONE MORPHOGENETIC PROTEIN 6; BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; LEUKEMIA INHIBITORY FACTOR; LEUKEMIA INHIBITORY FACTOR 1; MICROTUBULE ASSOCIATED PROTEIN 2; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; NEURTURIN; OSTEOGENIC PROTEIN 1; PERSEPHIN; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN INJURY; CELL FATE; CELL MIGRATION; CEREBRAL PALSY; CONTROLLED STUDY; CONVALESCENCE; EMBRYO; EXCITOTOXICITY; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN CELL; MALE; MEMORY; MOUSE; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NEURAL STEM CELL TRANSPLANTATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; PERINATAL PERIOD; PHENOTYPE; PRIORITY JOURNAL; SPATIAL MEMORY; TEMPORAL MEMORY; TREATMENT OUTCOME;

ANIMALS; ANIMALS, NEWBORN; BRAIN INJURIES; BRAIN TISSUE TRANSPLANTATION; CELL DIFFERENTIATION; CELL MOVEMENT; CEREBRAL PALSY; FEMALE; FETAL TISSUE TRANSPLANTATION; FETUS; FIBROBLASTS; HUMANS; IBOTENIC ACID; IMMUNOHISTOCHEMISTRY; INFANT, NEWBORN; MEMORY; MICE; MICE, INBRED C57BL; NEURAL STEM CELLS; NEURONS; OLIGODENDROGLIA; RECOVERY OF FUNCTION;

ANIMALIA;

EID: 79955752343     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2010.0302     Document Type: Article

References (70)

1. Allen MC. (2008). Neurodevelopmental outcomes of preterm infants. Curr Opin Neurol 21:123-128. (Pubitemid 351644151)
2. Robertson CM, MJ Watt and Y Yasui. (2007). Changes in the prevalence of cerebral palsy for children born very prematurely within a population-based program over 30 years. JAMA 297:2733-2740. (Pubitemid 47001099)
3. Vincer MJ, AC Allen, KS Joseph, DA Stinson, H Scott and E Wood. (2006). Increasing prevalence of cerebral palsy among very preterm infants: a population-based study. Pediatrics 118:e1621-e1626. (Pubitemid 46397534)
4. Wilson-Costello D, H Friedman, N Minich, B Siner, G Taylor, M Schluchter and M Hack. (2007). Improved neurodevelopmental outcomes for extremely low birth weight infants in 2000-2002. Pediatrics 119:37-45. (Pubitemid 46397840)
5. Deng W, J Pleasure and D Pleasure. (2008). Progress in periventricular leukomalacia. Arch Neurol 65:1291-1295.
6. Johnston MV. (2005). Excitotoxicity in perinatal brain injury. Brain Pathol 15:234-240. (Pubitemid 41161180)
7. Volpe JJ. (2005). Encephalopathy of prematurity includes neuronal abnormalities. Pediatrics 116:221-225.
8. Volpe JJ. (2001). Neurobiology of periventricular leukomalacia in the premature infant. Pediatr Res 50:553-562. (Pubitemid 33009976)
9. Craig A, N Ling Luo, DJ Beardsley, N Wingate-Pearse, DW Walker, AR Hohimer and SA Back. (2003). Quantitative analysis of perinatal rodent oligodendrocyte lineage progression and its correlation with human. Exp Neurol 181:231-240. (Pubitemid 36629244)
10. Inder TE, PS Huppi, S Warfield, R Kikinis, GP Zientara, PD Barnes, F Jolesz and JJ Volpe. (1999). Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann Neurol 46:755-760. (Pubitemid 29518137)
11. Kesler SR, B Vohr, KC Schneider, KH Katz, RW Makuch, AL Reiss and LR Ment. (2006). Increased temporal lobe gyrification in preterm children. Neuropsychologia 44:445-453. (Pubitemid 41821906)
12. Leviton A and P Gressens. (2007). Neuronal damage accompanies perinatal white-matter damage. Trends Neurosci 30:473-478. (Pubitemid 47374834)
13. Marlow N, D Wolke, MA Bracewell and M Samara; EPICure Study Group. (2005). Neurologic and developmental disability at six years of age after extremely preterm birth. N Engl J Med 352:9-19. (Pubitemid 40075676)
14. O'Shea M. (2008). Cerebral palsy. Semin Perinatol 32:35-41. (Pubitemid 351174363)
15. Cao Q, RL Benton and SR Whittemore. (2002). Stem cell repair of central nervous system injury. J Neurosci Res 68:501-510. (Pubitemid 34575616)
16. Conti L, T Cataudella and E Cattaneo. (2003). Neural stem cells: a pharmacological tool for brain diseases? Pharmacol Res 47:289-297. (Pubitemid 36315750)
17. Pluchino S, L Zanotti, B Rossi, E Brambilla, L Ottoboni, G Salani, M Martinello, A Cattalini, A Bergami, R Furlan, G Comi, G Constantin and G Martino. (2005). Neurospherederived multipotent precursors promote neuroprotection by an immunomodulatory mechanism. Nature 436:266-271. (Pubitemid 41021278)
18. Pluchino S, L Zanotti, E Brini, S Ferrari and G Martino. (2009). Regeneration and repair in multiple sclerosis: the role of cell transplantation. Neurosci Lett 456:101-106.
19. NeriM, C Maderna, D Ferrari, C Cavazzin, AL Vescovi and A Gritti. (2010). Robust generation of oligodendrocyte progenitors from human neural stem cells and engraftment in experimental demyelination models in mice. PLoS ONE 5:e10145.
20. Kim SU and J de Vellis. (2009). Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 87:2183-2200.
21. Pimentel-Coelho PM and R Mendez-Otero. (2010). Cell therapy for neonatal hypoxic-ischemic encephalopathy. Stem Cells Dev 19:299-310.
22. Alvarez-Buylla A and S Temple. (1998). Stem cells in the developing and adult nervous system. J Neurobiol 36:105-110. (Pubitemid 28363225)
23. Gage FH. (2000). Mammalian neural stem cells. Science 287:1433-1438. (Pubitemid 30127128)
24. Reynolds BA and S Weiss. (1992). Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710.
25. Sato Y, K Nakanishi, M Hayakawa, H Kakizawa, A Saito, Y Kuroda, M Ida, Y Tokita, S Aono, F Matsui, S Kojima and A Oohira. (2008). Reduction of brain injury in neonatal hypoxic- ischemic rats by intracerebroventricular injection of neural stem=progenitor cells together with chondroitinase ABC. Reprod Sci 15:613-620. (Pubitemid 351875962)
26. Zheng T, GP Marshall II 2nd, KA Chen and ED Laywell. (2009). Transplantation of neural stem=progenitor cells into developing and adult CNS. Methods Mol Biol 482:185-197.
27. Dommergues MA, J Patkai, JC Renauld, P Evrard and P Gressens. (2000). Proinflammatory cytokines and interleukin- 9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann Neurol 47:54-63. (Pubitemid 30033650)
28. Husson I, B Mesples, P Bac, J Vamecq, P Evrard and P Gressens. (2002). Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann Neurol 51:82-92. (Pubitemid 34027980)
29. Marret S, R Mukendi, JF Gadisseux, P Gressens and P Evrard. (1995). Effect of ibotenate on brain development: an excitotoxic mouse model of microgyria and posthypoxic-like lesions. J Neuropathol Exp Neurol 54:358-370.
30. Lelievre V, Z Hu, JY Byun, Y Ioffe and JA Waschek. (2002). Fibroblast growth factor-2 converts PACAP growth action on embryonic hindbrain precursors from stimulation to inhibition. J Neurosci Res 67:566-573. (Pubitemid 34202792)
31. Tropepe V, M Sibilia, BG Ciruna, J Rossant, EF Wagner and D van der Kooy. (1999). Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev Biol 208:166-188. (Pubitemid 29149456)
32. Zuker M. (2003). Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res 31:3406-3415. (Pubitemid 37442169)
33. Gressens P, S Marret, JM Hill, DE Brenneman, I Gozes, M Fridkin and P Evrard. (1997). Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J Clin Invest 100:390-397. (Pubitemid 27349086)
34. Olney JW, C Ikonomidou, JL Mosinger and G Frierdich. (1989). MK-801 prevents hypobaric-ischemic neuronal degeneration in infant rat brain. J Neurosci 9:1701-1704. (Pubitemid 19146265)
35. Husson I, CM Rangon, V Lelievre, AP Bemelmans, P Sachs, J Mallet, BE Kosofsky and P Gressens. (2005). BDNF-induced white matter neuroprotection and stage-dependent neuronal survival following a neonatal excitotoxic challenge. Cereb Cortex 15:250-261. (Pubitemid 40270194)
36. Tahraoui SL, S Marret, C Bodenant, P Leroux, MA Dommergues, P Evrard and P Gressens. (2001). Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol 11:56-71.
37. Walsh RN and RA Cummins. (1976). The Open-Field Test: a critical review. Psychol Bull 83:482-504.
38. Karl T, R Pabst and S von Horsten. (2003). Behavioral phenotyping of mice in pharmacological and toxicological research. Exp Toxicol Pathol 55:69-83. (Pubitemid 36975689)
39. Bevins RA and J Besheer. (2006). Object recognition in rats and mice: a one-trial non-matching-to-sample learning task to study "recognition memory". Nat Protoc 1:1306-1311.
40. Dere E, JP Huston and MA De Souza Silva. (2007). The pharmacology, neuroanatomy and neurogenetics of one-trial object recognition in rodents. Neurosci Biobehav Rev 31:673-704. (Pubitemid 46670336)
41. Rampon C, YP Tang, J Goodhouse, E Shimizu, M Kyin and JZ Tsien. (2000). Enrichment induces structural changes and recovery from nonspatial memory deficits in CA1 NMDAR1-knockout mice. Nat Neurosci 3:238-244. (Pubitemid 30140785)
42. Soderling SH, LK Langeberg, JA Soderling, SM Davee, R Simerly, J Raber and JD Scott. (2003). Loss of WAVE-1 causes sensorimotor retardation and reduced learning and memory in mice. Proc Natl Acad Sci U S A 100:1723-1728. (Pubitemid 36254515)
43. Dulawa SC, DK Grandy, MJ Low, MP Paulus and MA Geyer. (1999). Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli. J Neurosci 19:9550-9556. (Pubitemid 30228106)
44. Dommergues MA, F Plaisant, C Verney and P Gressens. (2003). Early microglial activation following neonatal excitotoxic brain damage in mice: a target for neuroprotection. Neuroscience 121:619-628. (Pubitemid 38367501)
45. Inder TE, SK Warfield, H Wang, PS Hüppi and JJ Volpe. (2005). Abnormal cerebral structure is present at term in premature infants. Pediatrics 115:286-294. (Pubitemid 43193809)
46. Okoshi Y, M Mizuguchi, M Itoh, A Oka and S Takashima. (2007). Altered nestin expression in the cerebrum with periventricular leukomalacia. Pediatr Neurol 36:170-174. (Pubitemid 46367527)
47. Modo M, RP Stroemer, E Tang, S Patel and H Hodges. (2002). Effects of implantation site of stem cell grafts on behavioral recovery from stroke damage. Stroke 33:2270-2278. (Pubitemid 35014642)
48. Imitola J, K Raddassi, KI Park, Mueller FJ, M Nieto, YD Teng, D Frenkel, J Li, RL Sidman, CA Walsh, EY Snyder and SJ Khoury. (2004). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha= CXC chemokine receptor 4 pathway. Proc Natl Acad Sci U S A 101:18117-18122. (Pubitemid 40054083)
49. Aharonowiz M, O Einstein, N Fainstein, H Lassmann, B Reubinoff and T Ben-Hur. (2008). Neuroprotective effect of transplanted human embryonic stem cell-derived neural precursors in an animal model of multiple sclerosis. PLoS ONE 3:e3145.
50. Ben-Hur T. (2008). Immunomodulation by neural stem cells. J Neurol Sci 265:102-104.
51. Einstein O and T Ben-Hur. (2008). The changing face of neural stem cell therapy in neurologic diseases. Arch Neurol 65:452-456. (Pubitemid 351549952)
52. Locatelli F, A Bersano, E Ballabio, S Lanfranconi, D Papadimitriou, S Strazzer, N Bresolin, GP Comi and S Corti. (2009). Stem cell therapy in stroke. Cell Mol Life Sci 66:757-772.
53. Bacigaluppi M, S Pluchino, L Peruzzotti Jametti, E Kilic, U Kilic, G Salani, E Brambilla, MJ West, G Comi, G Martino and DM Hermann. (2009). Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 132:2239-2251.
54. Mathieu P, D Battista, A Depino, V Roca, M Graciarena and F Pitossi. (2010). The more you have, the less you get: the functional role of inflammation on neuronal differentiation of endogenous and transplanted neural stem cells in the adult brain. J Neurochem 112:1368-1385.
55. Hampton DW, RA Asher, T Kondo, JD Steeves, MS Ramer and JW Fawcett. (2007). A potential role for bone morphogenetic protein signalling in glial cell fate determination following adult central nervous system injury in vivo. Eur J Neurosci 26:3024-3035. (Pubitemid 350135185)
56. Lee CS, LY Tee, S Dusenbery, T Takata, JP Golden, BA Pierchala, DI Gottlieb, EM Johnson Jr., DW Choi and BJ Snider. (2005). Neurotrophin and GDNF family ligands promote survival and alter excitotoxic vulnerability of neurons derived from murine embryonic stem cells. Exp Neurol 191:65-76. (Pubitemid 39612393)
57. Beurrier C,M Faideau, KE Bennouar, C Escartin, L Kerkerian- Le Goff, G Bonvento and P Gubellini. (2010). Ciliary neurotrophic factor protects striatal neurons against excitotoxicity by enhancing glial glutamate uptake. PLoS ONE 5:e8550.
58. Lee M, V Lelievre, P Zhao, M Torres, W Rodriguez, JY Byun, S Doshi, Y Ioffe, G Gupta, AE de los Monteros, J de Vellis and J Waschek. (2001). Pituitary adenylyl cyclase-activating polypeptide stimulates DNA synthesis but delays maturation of oligodendrocyte progenitors. J Neurosci 21:3849-3859. (Pubitemid 32466477)
59. Iannotti C, H Li, P Yan, X Lu, L Wirthlin and XM Xu. (2003). Glial cell line-derived neurotrophic factor-enriched bridging transplants promote propriospinal axonal regeneration and enhance myelination after spinal cord injury. Exp Neurol 183:379-393. (Pubitemid 37205080)
60. Barres BA, MC Raff, F Gaese, I Bartke, G Dechant and YA Barde. (2004). A crucial role for neurotrophin-3 in oligodendrocyte development. Nature 120:1097-1108.
61. Zeger M, G Popken, J Zhang, S Xuan, QR Lu, MH Schwab, KA Nave, D Rowitch, AJ D'Ercole and P Ye. (2007). Insulinlike growth factor type 1 receptor signaling in the cells of oligodendrocyte lineage is required for normal in vivo oligodendrocyte development and myelination. Glia 55:400-411.
62. Van Velthoven CT, A Kavelaars, F van Bel and CJ Heijnen. (2010). Mesenchymal stem cell treatment after neonatal hypoxic-ischemic brain injury improves behavioral outcome and induces neuronal and oligodendrocyte regeneration. Brain Behav Immun 24:387-393.
63. Lee JA, BI Kim, CH Jo, CW Choi, EK Kim, HS Kim, KS Yoon and JH Choi. (2010). Mesenchymal stem-cell transplantation for hypoxic-ischemic brain injury in neonatal rat model. Pediatr Res 67:42-46.
64. Sher F, V Balasubramaniyan, E Boddeke and S Copray. (2008). Oligodendrocyte differentiation and implantation: new insights for remyelinating cell therapy. Curr Opin Neurol 21:607-614.
65. Kondo Y and ID Duncan. (2009). Transplantation of oligodendrocyte progenitor cells in animal models of leukodystrophies. Methods Mol Biol 549:175-185.
66. Barres BA, MA Lazar and MC Raff. (1994). A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120: 1097-1108. (Pubitemid 24150036)
67. Jones SA, DM Jolson, KK Cuta, CN Mariash and GW Anderson. (2003). Triiodothyronine is a survival factor for developing oligodendrocytes. Mol Cell Endocrinol 199: 49-60. (Pubitemid 36170291)
68. Comi AM, E Cho, JD Mulholland, A Hooper, Q Li, Y Qu, DS Gary, JW McDonald and MV Johnston. (2008). Neural stem cells reduce brain injury after unilateral carotid ligation. Pediatr Neurol 38:86-92.
69. Adams HP Jr., G del Zoppo, MJ Alberts, DL Bhatt, L Brass, A Furlan, RL Grubb, RT Higashida, EC Jauch, C Kidwell, PD Lyden, LB Morgenstern, AI Qureshi, RH Rosenwasser, PA Scott and EF Wijdicks. (2007). Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association=American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 38:1655-1711. (Pubitemid 46691097)
70. Moritani T, WR Smoker, Y Sato, Y Numaguchi and PL Westesson. (2005). Diffusion-weighted imaging of acute excitotoxic brain injury. Am J Neuroradiol 26:216-228. (Pubitemid 43073296)